Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Recruiting 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Dermatologic 1CNS 1

Conditions

Lung Neoplasms 2Social Stigma 1Prostatic Neoplasms 1Noonan Syndrome 1Neurofibromatosis 1 1Neoplasm Metastasis 1Multiple Myeloma 1Lymphoma, Follicular 1Legius syndrome 1Hematologic Neoplasms 1Genetic Diseases, Inborn 1Generalized Anxiety Disorder 1Disease 1Costello Syndrome 1Cardiofaciocutaneous syndrome 1Breast Neoplasms 1Anxiety Disorders 1

Interventions

AZD 6244 12trametinib 4mirdametinib 2fludarabine 2Lasers, Solid-State 2Inhalation 2Deoxycholic Acid 2Acetylcysteine 2thymoglobulin 1talimogene laherparepvec 1omipalisib 1lorlatinib 1fludarabine phosphate 1encorafenib 1dabrafenib 1cabozantinib 1binimetinib 1abemaciclib 1Waiting Lists 1Vincristine 1Specimen Handling 1Sirolimus 1Rituximab 1Radiation 1Polidocanol 1N-monoacetylcystine 1Melphalan 1Magnetic Resonance Spectroscopy 1Lovastatin 1Liquid Biopsy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Neurofibromatosis 1 × Waiting Lists × 1 year × Clear all
NCT05361811 2026-02-19

Acceptance and Commitment Therapy for Caregivers of Children With a RASopathy: An Internal Pilot Feasibility Study and Follow-up Randomized Controlled Trial

National Institutes of Health Clinical Center (CC)

Phase NA Recruiting
70 enrolled
CNSDermatologic

Cardiofaciocutaneous syndrome, Legius syndrome, Neurofibromatosis 1, Noonan Syndrome, Genetic Diseases, Inborn, Costello Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon âš¡